Skip to main content
Smart Investors Daily
HT

OTC · HTDS

Hard to Treat Diseases Inc.

Healthcare · Biotechnology

$0.00

Up+$0.00 (+0.00%)

Updated Oct 12, 2026, 3:42 PM

SID Score

3.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
109.65K
P/E ratio
—
Dividend yield
—
52-week range
$0.00 – $0.00
Volume
30K
Avg. volume
227.19K

Price performance · HTDS

HTDS price history

1M range · 11 trading sessions · Daily adjusted prices

Prices through Oct 7, 2026

HTDS closed at $0.00 after 11 trading sessions.

Last close
$0.00
Period change
—
Period low
$0.00
Period high
$0.00
Daily close
View OHLC price history
HTDS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 7, 2026$0.00$0.00$0.00$0.0030K
Oct 5, 2026$0.00$0.00$0.00$0.007.7K
Oct 2, 2026$0.00$0.00$0.00$0.00603.5K
Sep 30, 2026$0.00$0.00$0.00$0.0020K
Sep 24, 2026$0.00$0.00$0.00$0.0010K
Sep 22, 2026$0.00$0.00$0.00$0.00100K
Sep 21, 2026$0.00$0.00$0.00$0.0011.6K
Sep 18, 2026$0.00$0.00$0.00$0.00100K
Sep 17, 2026$0.00$0.00$0.00$0.0010.09M
Sep 15, 2026$0.00$0.00$0.00$0.00233.33K
Sep 14, 2026$0.00$0.00$0.00$0.00100K

Latest HTDS news

The latest Smart Investors Daily articles mentioning HTDS.

HTDS research

Overview

Company profile and research snapshot.

Company profile

HARD TO TREAT DISEASES

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.